Genetic risks of antiviral nucleoside analogues – a survey

This publication has 69 references indexed in Scilit:

• Comparison of the genotoxic and apoptosis-inducing properties of ganciclovir and penciclovir in Chinese hamster ovary cells transfected with the thymidine kinase gene of herpes simplex virus-1: Implications for gene therapeutic approaches
  Cancer Gene Therapy, 2000
• Solution Structure of a DNA Decamer Containing the Antiviral Drug Ganciclovir: Combined Use of NMR, Restrained Molecular Dynamics, and Full Relaxation Matrix Refinement
  Biochemistry, 1997
• Cytogenetic genotoxicity of antiherpes virostatics in Chinese hamster V79-E cells. I. Purine nucleoside analogues
  Antiviral Research, 1996
• Different Mechanisms of Inhibition of DNA Synthesis by (E)-5-(2-Bromovinyl)-2′-deoxyuridine in Cells Transfected with Gene for Thymidine Kinase of Herpes Simplex Virus Type 1 and in Cells Infected with the Virus
  Nucleosides and Nucleotides, 1995
• Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives
  International Journal of Clinical Pharmacy, 1994
• Genotoxic properties of (E)-5-(2-bromovinyl)-2?-deoxyuridine (BVDU)
  Fundamental and Applied Toxicology, 1992
• Induction of micronuclei in mouse bone marrow cells: An evaluation of nucleoside analogues used in the treatment of AIDS
  Environmental and Molecular Mutagenesis, 1991
• Mutagenic potential of anti-herpes agents
  Life Sciences, 1986
• Potent anti-viral 5-(2-bromovinyl) uracil nucleosides are inactive at inducing gene mutations in Salmonella typhimurium and V79 Chinese hamster cells and unscheduled DNA synthesis in primary rat hepatocytes
  Carcinogenesis: Integrative Cancer Research, 1985
• Preclinical toxicology studies with acyclovir: Genetic toxicity tests
  Fundamental and Applied Toxicology, 1983